Recommended Topic Related To:

Nilandron

"The U.S. Food and Drug Administration today approved Xofigo (radium Ra 223 dichloride) to treat men with symptomatic late-stage (metastatic) castration-resistant prostate cancer that has spread to bones but not to other organs. It is intended for"...

Nilandron

Indications
Dosage
How Supplied

INDICATIONS

Metastatic Prostate Cancer

NILANDRON (nilutamide) tablets are indicated for use in combination with surgical castration for the treatment of metastatic prostate cancer (Stage D2).

For maximum benefit, NILANDRON (nilutamide) treatment must begin on the same day as or on the day after surgical castration.

DOSAGE AND ADMINISTRATION

The recommended dosage is 300 mg once a day for 30 days, followed thereafter by 150 mg once a day. NILANDRON (nilutamide) tablets can be taken with or without food.

HOW SUPPLIED

NILANDRON (nilutamide) 150 mg tablets are supplied in boxes of 30 tablets. Each box contains 3 child-resistant, PVC, aluminum foil-backed blisters of 10 tablets (NDC 0088-1111-14). Each white, biconvex, cylindrical (10 mm in diameter) tablet has a triangular logo on one side and an internal reference number (168D) on the other.

Store at 25°C (77°F); excursions permitted between 15-30°C (59-86°F) [see USP Controlled Room Temperature]. Protect from light.

Revised June 2006. Sanofi-aventis U.S. LLC Bridgewater, NJ 08807. Country of Origin: France. FDA Rev date: 7/26/2004

Last reviewed on RxList: 10/14/2008
This monograph has been modified to include the generic and brand name in many instances.

Indications
Dosage
How Supplied
A A A

Nilandron - User Reviews

Nilandron User Reviews

Now you can gain knowledge and insight about a drug treatment with Patient Discussions.

Here is a collection of user reviews for the medication Nilandron sorted by most helpful. Patient Discussions FAQs

Report Problems to the Food and Drug Administration

 

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.


Cancer

Get the latest treatment options.


NIH talks about Ebola on WebMD